Rafferty Asset Management’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RVMD
BBA
DGM
Rafferty Asset Management's RVMD Position: Q3 2026 in Review
Rafferty Asset Management increased its Revolution Medicines (RVMD) stake by 61% in Q3 2026, buying an estimated $2.3M and bringing the position to 30,763 shares worth $6.31M. The position accounts for 0.02% of the portfolio, ranked #328.
Rafferty Asset Management first reported a position in RVMD in Q3 2020 and has held it in 25 quarters since. The position peaked at $10.5M in Q4 2023. 758 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.
- Rafferty Asset Management held 30,763 shares of Revolution Medicines worth $6.31M as of Q3 2026.
- Rafferty Asset Management bought 11,618 Revolution Medicines shares in Q3 2026, an estimated $2.3M.
- Revolution Medicines made up 0.02% of Rafferty Asset Management's portfolio in Q3 2026, its #328 holding.
- Rafferty Asset Management first reported a position in Revolution Medicines in Q3 2020 and has held it in 25 quarters since.
- Rafferty Asset Management's Revolution Medicines position peaked at $10.5M in Q4 2023.
- 758 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.
Based on Rafferty Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.